Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban

2001 New England Journal of Medicine 2,101 citations

Abstract

In patients with unstable angina and myocardial infarction without ST-segment elevation who were treated with the glycoprotein IIb/IIIa inhibitor tirofiban, the use of an early invasive strategy significantly reduced the incidence of major cardiac events. These data support a policy involving broader use of the early inhibition of glycoprotein IIb/IIIa in combination with an early invasive strategy in such patients.

Keywords

TirofibanMedicineCardiologyInternal medicineAcute coronary syndromePercutaneous coronary interventionMyocardial infarction

Affiliated Institutions

Related Publications

Publication Info

Year
2001
Type
article
Volume
344
Issue
25
Pages
1879-1887
Citations
2101
Access
Closed

External Links

Citation Metrics

2101
OpenAlex

Cite This

Christopher P. Cannon, William S. Weintraub, Laura A. Demopoulos et al. (2001). Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban. New England Journal of Medicine , 344 (25) , 1879-1887. https://doi.org/10.1056/nejm200106213442501

Identifiers

DOI
10.1056/nejm200106213442501